Dehydroepiandrosterone sulfate measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
18
|
27
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2019 |
Adiponectin Measurement
|
phenotype |
|
Laboratory Procedure
|
25
|
70
|
0.100 |
None |
1.000 |
2 |
1
|
2012 |
2014 |
Specific language impairment
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
34
|
9
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2017 |
AIDS-Associated Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
45
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Idiopathic Nephrotic Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
51
|
72
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Nephrotic Syndrome, Minimal Change
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
85
|
10
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Language Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
94
|
25
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2013 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Dyslexia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
118
|
30
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2014 |
Physical Activity Measurement
|
phenotype |
|
Laboratory Procedure
|
160
|
355
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Cholera
|
disease |
Infections
|
Disease or Syndrome
|
209
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hematuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
235
|
31
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Smoking Behaviors
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
249
|
742
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
2 |
1
|
2010 |
2013 |
Pervasive Development Disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
328
|
49
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2017 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Lupus Nephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
503
|
64
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2017 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
10 |
2
|
2010 |
2019 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
3 |
2
|
2018 |
2019 |